{"gene":"PDE6C","run_date":"2026-04-29T11:37:58","timeline":{"discoveries":[{"year":2009,"finding":"PDE6C encodes the cone alpha' (catalytic) subunit of cGMP phosphodiesterase, which converts cGMP to 5'-GMP and is an essential effector enzyme in cone phototransduction; missense mutations (p.R29W, p.Y323N) in PDE6C cause cone photoreceptor disorders by disrupting this catalytic function.","method":"Homozygosity mapping, Sanger sequencing, functional inference from known enzyme activity","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — foundational identification of PDE6C as cone cGMP-PDE catalytic subunit, replicated across multiple families and corroborated by biochemical studies in subsequent work","pmids":["19615668"],"is_preprint":false},{"year":2009,"finding":"Mutations in PDE6C (encoding the catalytic subunit of cone photoreceptor phosphodiesterase) cause autosomal recessive achromatopsia in humans; the spontaneous cpfl1 mouse carries a homologous Pde6c mutation and recapitulates loss of cone function and rapid cone photoreceptor degeneration, establishing Pde6c as essential for cone cell survival.","method":"Genetic mapping, sequencing, ERG functional testing, histological analysis of cpfl1 mouse model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — orthologous mouse model with functional (ERG) and structural validation, replicated across human patients","pmids":["19887631"],"is_preprint":false},{"year":2010,"finding":"Six missense mutations in PDE6C (expressed as chimeric PDE6C/PDE5 proteins in Sf9 insect cells) were characterized biochemically: four mutations (including p.R104W, p.P391L, p.H602L) produced near-zero PDE activity (functional null alleles); p.E790K reduced activity ~60% and increased sensitivity to inhibitory Pγ subunit (IC₅₀ 2.7 nM, 20.7-fold more sensitive); p.Y323N reduced activity ~80% and decreased Pγ sensitivity (IC₅₀ 158 nM, 3-fold less sensitive than wild-type).","method":"Baculovirus expression in Sf9 cells, PDE activity assay, Western blotting, zaprinast and Pγ inhibition assays, minigene splice assays","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro enzymatic assays with multiple mutants, quantitative IC50 determination, multiple orthogonal methods","pmids":["21127010"],"is_preprint":false},{"year":2014,"finding":"PDE6C missense mutants display distinct mechanisms in transgenic Xenopus laevis rods: mutations in the catalytic domain (H602L, E790K) modestly reduce proteolytic stability but allow proper outer segment targeting; mutations in GAF regulatory domains (R104W, Y323N, P391L) cause proteolytic degradation via cleavage in the GAFb domain; mutations R29W and M455V (outside conserved domains) produce aberrant subcellular compartmentalization distinct from wild-type PDE6C.","method":"Transgenic Xenopus laevis expression, subcellular fractionation, proteolytic stability assays, immunofluorescence localization","journal":"Molecular and cellular neurosciences","confidence":"High","confidence_rationale":"Tier 1-2 — direct expression in photoreceptors with fractionation, proteolytic assays, and localization across multiple mutants in a single study","pmids":["25461672"],"is_preprint":false},{"year":2014,"finding":"In pde6c(w59) zebrafish, cone photoreceptors undergo necroptotic cell death mediated by elevated RIP1 and RIP3 kinase activity; rod photoreceptors die via caspase-3-dependent apoptosis as bystander cells. Morpholino knockdown of rip3 rescued dying cones by inhibiting reactive oxygen species formation and suppressing second-order neuron remodelling, and upregulated rod phosphodiesterase genes (pde6a, pde6b) to compensate for absent cone pde6c.","method":"Zebrafish pde6c(w59) mutant, morpholino knockdown, immunostaining for RIP1/RIP3/caspase-3, pharmacological RIP1/RIP3 inhibition, ROS assays, visual function assessment","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 — genetic (morpholino) and pharmacological epistasis with multiple cellular readouts in an established zebrafish model","pmids":["24413151"],"is_preprint":false},{"year":2017,"finding":"Aipl1b (cone-specific AIPL1 ortholog) is required for the stability of Pde6c in zebrafish cone photoreceptors; loss of aipl1b dramatically reduces Pde6c protein levels, and aipl1b genetically interacts with pde6c in the eclipse mutant. Additionally, cone-specific guanylate cyclase zGc3 is interdependent with Pde6c—zGc3 knockdown causes marked reduction of Pde6c, placing AIPL1, PDE6C, and GC3 in a mutually dependent stability network in cones.","method":"Zebrafish aipl1b mutant (gosh), genetic interaction (double mutant analysis), morpholino knockdown of zGc3, immunostaining for Pde6c and zGc3 protein levels","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis and loss-of-function with protein-level readout using multiple orthogonal approaches","pmids":["28378769"],"is_preprint":false},{"year":1995,"finding":"The human PDE6C gene (then called PDEA2) spans ~48 kb, contains 22 exons, encodes an 858-amino-acid protein, and maps to chromosome 10q24; its intron-exon organization is highly similar to that of rod beta-PDE, indicating close phylogenetic relationship and likely common origin.","method":"Genomic cloning, sequence analysis, chromosomal localization by mapping","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — direct genomic characterization establishing gene structure, single study","pmids":["7490077"],"is_preprint":false},{"year":2022,"finding":"A cis-regulatory enhancer located within an intron of Pde6c drives transient, cone-enriched expression in developing mouse and human retinal organoids; mutagenesis of the enhancer identified five or more essential transcription factor binding sites, implicating both known photoreceptor regulators and novel families in cone fate specification.","method":"Electroporation of enhancer-reporter constructs in mouse retina, transgenic human iPSC-derived retinal organoids, enhancer deletion/mutagenesis series","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct functional enhancer assay with mutagenesis in two systems (mouse and human organoids), single lab","pmids":["35644251"],"is_preprint":false}],"current_model":"PDE6C encodes the catalytic alpha' subunit of the cone photoreceptor cGMP-phosphodiesterase (PDE6), which hydrolyzes cGMP to 5'-GMP in the phototransduction cascade; its activity is regulated by the inhibitory Pγ subunit, its stability in cones depends on AIPL1 and guanylate cyclase GC3, and disease-causing missense mutations produce distinct molecular defects—including loss of catalytic activity, altered Pγ sensitivity, proteolytic degradation via the GAFb domain, or mislocalization to non-outer-segment compartments—while loss of PDE6C function triggers RIP1/RIP3-mediated necroptotic cone death and secondary caspase-dependent rod bystander death."},"narrative":{"teleology":[{"year":1995,"claim":"Establishing the genomic architecture of PDE6C resolved a foundational question about the structural relationship between cone and rod PDE catalytic subunits, revealing high conservation and a common evolutionary origin.","evidence":"Genomic cloning, exon-intron mapping, and chromosomal localization of the human PDE6C (PDEA2) gene","pmids":["7490077"],"confidence":"Medium","gaps":["No functional or biochemical data on the encoded protein were provided","Regulatory elements controlling cone-specific expression were not identified"]},{"year":2009,"claim":"Identification of PDE6C as the disease gene for autosomal recessive achromatopsia established that the cone α′ PDE6 subunit is indispensable for cone function and survival, linking a specific phototransduction enzyme to a human Mendelian cone disorder.","evidence":"Homozygosity mapping and sequencing in human achromatopsia families; ERG, histology, and genetic analysis of the cpfl1 mouse carrying a homologous Pde6c mutation","pmids":["19615668","19887631"],"confidence":"High","gaps":["Biochemical consequences of individual patient mutations were unknown","Mechanism of cone cell death downstream of PDE6C loss was uncharacterized"]},{"year":2010,"claim":"Biochemical characterization of six patient-derived missense mutations revealed that PDE6C disease alleles are not mechanistically uniform: some are catalytic nulls, while others differentially alter Pγ inhibitory sensitivity, indicating that both enzymatic activity and regulatory interactions are critical for cone PDE6 function.","evidence":"Baculovirus expression of chimeric PDE6C/PDE5 proteins in Sf9 cells with PDE activity assays, zaprinast inhibition, and quantitative Pγ IC50 determinations","pmids":["21127010"],"confidence":"High","gaps":["Assays used a chimeric PDE6C/PDE5 construct rather than full-length native PDE6C holoenzyme","Whether altered Pγ sensitivity translates to distinct disease severity in vivo was not tested"]},{"year":2014,"claim":"Two studies resolved the downstream consequences of PDE6C loss at the cellular and protein-folding levels: GAF-domain mutations cause proteolytic degradation via the GAFb domain while catalytic-domain mutations permit outer-segment targeting, and loss of PDE6C activity triggers necroptotic (RIP1/RIP3-mediated) cone death with secondary caspase-dependent rod bystander apoptosis.","evidence":"Transgenic Xenopus laevis rod expression with subcellular fractionation, proteolytic stability assays, and immunofluorescence; zebrafish pde6c(w59) mutant with morpholino knockdown, RIP1/RIP3/caspase-3 immunostaining, pharmacological inhibition, and ROS assays","pmids":["25461672","24413151"],"confidence":"High","gaps":["Transgenic expression was in rods rather than native cone photoreceptors","Whether necroptosis is the death pathway in mammalian cones lacking PDE6C is unknown","Mechanism by which GAFb-domain cleavage is initiated remains unresolved"]},{"year":2017,"claim":"Demonstration that PDE6C stability depends on AIPL1 and guanylate cyclase GC3 revealed a mutual protein-stabilization network specific to cones, explaining why AIPL1 mutations phenocopy PDE6C loss.","evidence":"Zebrafish aipl1b (gosh) mutant genetic interaction analysis, morpholino knockdown of zGc3, immunostaining for Pde6c and zGc3 protein levels","pmids":["28378769"],"confidence":"High","gaps":["Direct physical interactions among AIPL1, PDE6C, and GC3 were not demonstrated biochemically","Whether the stabilization network operates identically in mammalian cones is untested"]},{"year":2022,"claim":"Discovery of a cis-regulatory enhancer within a Pde6c intron that drives cone-enriched expression identified specific transcription factor binding sites required for cone-specific gene regulation, extending understanding from protein function to transcriptional control.","evidence":"Enhancer-reporter electroporation in mouse retina and transgenic human iPSC-derived retinal organoids with systematic enhancer mutagenesis","pmids":["35644251"],"confidence":"Medium","gaps":["The upstream transcription factors binding these sites were not all identified","Whether this enhancer is necessary for endogenous PDE6C expression (via enhancer knockout) was not shown"]},{"year":null,"claim":"The structure of the native cone PDE6C holoenzyme, the precise chaperone mechanism by which AIPL1 folds PDE6C, and whether therapeutic rescue of PDE6C in mammalian cones can prevent necroptotic degeneration remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of the cone PDE6C holoenzyme exists","Chaperone mechanism of AIPL1 for PDE6C folding/assembly is uncharacterized","Gene therapy rescue of PDE6C-null mammalian cones has not been demonstrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,2]}],"localization":[{"term_id":"GO:0005929","term_label":"cilium","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[0,1,2]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[4]}],"complexes":["Cone PDE6 holoenzyme"],"partners":["PDE6H","AIPL1","GUCY2F"],"other_free_text":[]},"mechanistic_narrative":"PDE6C encodes the catalytic α′ subunit of cone photoreceptor cGMP phosphodiesterase (PDE6), which hydrolyzes cGMP to 5′-GMP as the essential effector enzyme of cone phototransduction [PMID:19615668, PMID:19887631]. Its catalytic activity is modulated by the inhibitory Pγ subunit, with disease-causing missense mutations producing distinct molecular defects: catalytic-domain mutations (e.g., H602L, E790K) abolish or reduce enzymatic activity and alter Pγ sensitivity, whereas GAF-domain mutations (R104W, Y323N, P391L) cause proteolytic degradation via cleavage in the GAFb domain, and mutations outside conserved domains (R29W, M455V) lead to aberrant subcellular compartmentalization [PMID:21127010, PMID:25461672]. PDE6C protein stability in cones depends on a mutual stabilization network with AIPL1 and guanylate cyclase GC3, and loss of PDE6C triggers RIP1/RIP3-mediated necroptotic cone death with secondary caspase-dependent rod bystander degeneration [PMID:28378769, PMID:24413151]. Biallelic loss-of-function mutations in PDE6C cause autosomal recessive achromatopsia [PMID:19615668, PMID:19887631]."},"prefetch_data":{"uniprot":{"accession":"P51160","full_name":"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'","aliases":["cGMP phosphodiesterase 6C"],"length_aa":858,"mass_kda":99.1,"function":"As cone-specific cGMP phosphodiesterase, it plays an essential role in light detection and cone phototransduction by rapidly decreasing intracellular levels of cGMP","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P51160/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PDE6C","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PDE6C","total_profiled":1310},"omim":[{"mim_id":"613093","title":"CONE DYSTROPHY 4; COD4","url":"https://www.omim.org/entry/613093"},{"mim_id":"608866","title":"FRA10A-ASSOCIATED CGG REPEAT 1; FRA10AC1","url":"https://www.omim.org/entry/608866"},{"mim_id":"605080","title":"CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-3; CNGB3","url":"https://www.omim.org/entry/605080"},{"mim_id":"600827","title":"PHOSPHODIESTERASE 6C; PDE6C","url":"https://www.omim.org/entry/600827"},{"mim_id":"600053","title":"CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-3; CNGA3","url":"https://www.omim.org/entry/600053"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"retina","ntpm":21.4}],"url":"https://www.proteinatlas.org/search/PDE6C"},"hgnc":{"alias_symbol":["PDEA2","ACHM5","COD4"],"prev_symbol":[]},"alphafold":{"accession":"P51160","domains":[{"cath_id":"-","chopping":"7-36","consensus_level":"high","plddt":75.8873,"start":7,"end":36},{"cath_id":"3.30.450.40","chopping":"76-235","consensus_level":"high","plddt":91.5683,"start":76,"end":235},{"cath_id":"3.30.450.40","chopping":"254-287_307-442","consensus_level":"high","plddt":87.9047,"start":254,"end":442},{"cath_id":"1.10.1300.10","chopping":"499-814","consensus_level":"medium","plddt":95.1315,"start":499,"end":814}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51160","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51160-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51160-F1-predicted_aligned_error_v6.png","plddt_mean":88.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PDE6C","jax_strain_url":"https://www.jax.org/strain/search?query=PDE6C"},"sequence":{"accession":"P51160","fasta_url":"https://rest.uniprot.org/uniprotkb/P51160.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51160/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51160"}},"corpus_meta":[{"pmid":"19615668","id":"PMC_19615668","title":"Homozygosity mapping reveals PDE6C mutations in patients with early-onset cone photoreceptor disorders.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19615668","citation_count":170,"is_preprint":false},{"pmid":"19887631","id":"PMC_19887631","title":"A homologous genetic basis of the murine cpfl1 mutant and human achromatopsia linked to mutations in the PDE6C gene.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19887631","citation_count":162,"is_preprint":false},{"pmid":"24413151","id":"PMC_24413151","title":"Rip3 knockdown rescues photoreceptor cell death in blind pde6c zebrafish.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/24413151","citation_count":56,"is_preprint":false},{"pmid":"21127010","id":"PMC_21127010","title":"Decreased catalytic activity and altered activation properties of PDE6C mutants associated with autosomal recessive achromatopsia.","date":"2010","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21127010","citation_count":54,"is_preprint":false},{"pmid":"30080950","id":"PMC_30080950","title":"Mutations in the gene PDE6C encoding the catalytic subunit of the cone photoreceptor phosphodiesterase in patients with achromatopsia.","date":"2018","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/30080950","citation_count":27,"is_preprint":false},{"pmid":"26930483","id":"PMC_26930483","title":"A Naturally-Derived Compound Schisandrin B Enhanced Light Sensation in the pde6c Zebrafish Model of Retinal Degeneration.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26930483","citation_count":26,"is_preprint":false},{"pmid":"7490077","id":"PMC_7490077","title":"Gene structure and amino acid sequence of the human cone photoreceptor cGMP-phosphodiesterase alpha' subunit (PDEA2) and its chromosomal localization to 10q24.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7490077","citation_count":19,"is_preprint":false},{"pmid":"28378769","id":"PMC_28378769","title":"Aipl1 is required for cone photoreceptor function and survival through the stability of Pde6c and Gc3 in zebrafish.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28378769","citation_count":18,"is_preprint":false},{"pmid":"33001157","id":"PMC_33001157","title":"PDE6C: Novel Mutations, Atypical Phenotype, and Differences Among Children and Adults.","date":"2020","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/33001157","citation_count":12,"is_preprint":false},{"pmid":"31602821","id":"PMC_31602821","title":"Chitin deacetylases Cod4 and Cod7 are involved in polar growth of Aspergillus fumigatus.","date":"2019","source":"MicrobiologyOpen","url":"https://pubmed.ncbi.nlm.nih.gov/31602821","citation_count":11,"is_preprint":false},{"pmid":"29231925","id":"PMC_29231925","title":"Expression profiling of the retina of pde6c, a zebrafish model of retinal degeneration.","date":"2017","source":"Scientific data","url":"https://pubmed.ncbi.nlm.nih.gov/29231925","citation_count":10,"is_preprint":false},{"pmid":"25461672","id":"PMC_25461672","title":"Distinct patterns of compartmentalization and proteolytic stability of PDE6C mutants linked to achromatopsia.","date":"2014","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/25461672","citation_count":9,"is_preprint":false},{"pmid":"25605338","id":"PMC_25605338","title":"Congenital Achromatopsia and Macular Atrophy Caused by a Novel Recessive PDE6C Mutation (p.E591K).","date":"2015","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25605338","citation_count":7,"is_preprint":false},{"pmid":"35422133","id":"PMC_35422133","title":"A new mutation in the PDE6C gene in achromatopsia.","date":"2022","source":"European journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/35422133","citation_count":3,"is_preprint":false},{"pmid":"35644251","id":"PMC_35644251","title":"An enhancer located in a Pde6c intron drives transient expression in the cone photoreceptors of developing mouse and human retinas.","date":"2022","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35644251","citation_count":3,"is_preprint":false},{"pmid":"31520890","id":"PMC_31520890","title":"Generation of an induced pluripotent stem cell line (FRIMOi007-A) derived from an incomplete achromatopsia patient carrying a novel homozygous mutation in PDE6C gene.","date":"2019","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31520890","citation_count":3,"is_preprint":false},{"pmid":"32787476","id":"PMC_32787476","title":"Two novel PDE6C gene mutations in Chinese family with achromatopsia.","date":"2020","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32787476","citation_count":2,"is_preprint":false},{"pmid":"34720973","id":"PMC_34720973","title":"Two Novel Disease-Causing Variants in the PDE6C Gene Underlying Achromatopsia.","date":"2021","source":"Case reports in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/34720973","citation_count":2,"is_preprint":false},{"pmid":"32306724","id":"PMC_32306724","title":"Novel Bi-allelic PDE6C Variant Leads to Congenital Achromatopsia.","date":"2020","source":"Iranian biomedical journal","url":"https://pubmed.ncbi.nlm.nih.gov/32306724","citation_count":1,"is_preprint":false},{"pmid":"39641747","id":"PMC_39641747","title":"Onset and Progression of Disease in Nonhuman Primates With PDE6C Cone Disorder.","date":"2024","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/39641747","citation_count":1,"is_preprint":false},{"pmid":"38956522","id":"PMC_38956522","title":"Clinical characterizations and molecular genetic study of two co-segregating variants in PDZD7 and PDE6C genes leading simultaneously to non-syndromic hearing loss and achromatopsia.","date":"2024","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/38956522","citation_count":1,"is_preprint":false},{"pmid":"41995141","id":"PMC_41995141","title":"A Dynamic Change of Microglial States Occurs During the Transition From Photoreceptor Degeneration to Regeneration in Zebrafish pde6c Mutants.","date":"2026","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/41995141","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.02.14.638316","title":"Molecular Mechanisms Limiting the Therapeutic Window of AAV Gene Therapy in Mouse Models of Blue Cone Monochromacy","date":"2025-02-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.14.638316","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12085,"output_tokens":2250,"usd":0.035002},"stage2":{"model":"claude-opus-4-6","input_tokens":5551,"output_tokens":2019,"usd":0.117345},"total_usd":0.152347,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"PDE6C encodes the cone alpha' (catalytic) subunit of cGMP phosphodiesterase, which converts cGMP to 5'-GMP and is an essential effector enzyme in cone phototransduction; missense mutations (p.R29W, p.Y323N) in PDE6C cause cone photoreceptor disorders by disrupting this catalytic function.\",\n      \"method\": \"Homozygosity mapping, Sanger sequencing, functional inference from known enzyme activity\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational identification of PDE6C as cone cGMP-PDE catalytic subunit, replicated across multiple families and corroborated by biochemical studies in subsequent work\",\n      \"pmids\": [\"19615668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Mutations in PDE6C (encoding the catalytic subunit of cone photoreceptor phosphodiesterase) cause autosomal recessive achromatopsia in humans; the spontaneous cpfl1 mouse carries a homologous Pde6c mutation and recapitulates loss of cone function and rapid cone photoreceptor degeneration, establishing Pde6c as essential for cone cell survival.\",\n      \"method\": \"Genetic mapping, sequencing, ERG functional testing, histological analysis of cpfl1 mouse model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — orthologous mouse model with functional (ERG) and structural validation, replicated across human patients\",\n      \"pmids\": [\"19887631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Six missense mutations in PDE6C (expressed as chimeric PDE6C/PDE5 proteins in Sf9 insect cells) were characterized biochemically: four mutations (including p.R104W, p.P391L, p.H602L) produced near-zero PDE activity (functional null alleles); p.E790K reduced activity ~60% and increased sensitivity to inhibitory Pγ subunit (IC₅₀ 2.7 nM, 20.7-fold more sensitive); p.Y323N reduced activity ~80% and decreased Pγ sensitivity (IC₅₀ 158 nM, 3-fold less sensitive than wild-type).\",\n      \"method\": \"Baculovirus expression in Sf9 cells, PDE activity assay, Western blotting, zaprinast and Pγ inhibition assays, minigene splice assays\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro enzymatic assays with multiple mutants, quantitative IC50 determination, multiple orthogonal methods\",\n      \"pmids\": [\"21127010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PDE6C missense mutants display distinct mechanisms in transgenic Xenopus laevis rods: mutations in the catalytic domain (H602L, E790K) modestly reduce proteolytic stability but allow proper outer segment targeting; mutations in GAF regulatory domains (R104W, Y323N, P391L) cause proteolytic degradation via cleavage in the GAFb domain; mutations R29W and M455V (outside conserved domains) produce aberrant subcellular compartmentalization distinct from wild-type PDE6C.\",\n      \"method\": \"Transgenic Xenopus laevis expression, subcellular fractionation, proteolytic stability assays, immunofluorescence localization\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct expression in photoreceptors with fractionation, proteolytic assays, and localization across multiple mutants in a single study\",\n      \"pmids\": [\"25461672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In pde6c(w59) zebrafish, cone photoreceptors undergo necroptotic cell death mediated by elevated RIP1 and RIP3 kinase activity; rod photoreceptors die via caspase-3-dependent apoptosis as bystander cells. Morpholino knockdown of rip3 rescued dying cones by inhibiting reactive oxygen species formation and suppressing second-order neuron remodelling, and upregulated rod phosphodiesterase genes (pde6a, pde6b) to compensate for absent cone pde6c.\",\n      \"method\": \"Zebrafish pde6c(w59) mutant, morpholino knockdown, immunostaining for RIP1/RIP3/caspase-3, pharmacological RIP1/RIP3 inhibition, ROS assays, visual function assessment\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic (morpholino) and pharmacological epistasis with multiple cellular readouts in an established zebrafish model\",\n      \"pmids\": [\"24413151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Aipl1b (cone-specific AIPL1 ortholog) is required for the stability of Pde6c in zebrafish cone photoreceptors; loss of aipl1b dramatically reduces Pde6c protein levels, and aipl1b genetically interacts with pde6c in the eclipse mutant. Additionally, cone-specific guanylate cyclase zGc3 is interdependent with Pde6c—zGc3 knockdown causes marked reduction of Pde6c, placing AIPL1, PDE6C, and GC3 in a mutually dependent stability network in cones.\",\n      \"method\": \"Zebrafish aipl1b mutant (gosh), genetic interaction (double mutant analysis), morpholino knockdown of zGc3, immunostaining for Pde6c and zGc3 protein levels\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis and loss-of-function with protein-level readout using multiple orthogonal approaches\",\n      \"pmids\": [\"28378769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The human PDE6C gene (then called PDEA2) spans ~48 kb, contains 22 exons, encodes an 858-amino-acid protein, and maps to chromosome 10q24; its intron-exon organization is highly similar to that of rod beta-PDE, indicating close phylogenetic relationship and likely common origin.\",\n      \"method\": \"Genomic cloning, sequence analysis, chromosomal localization by mapping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct genomic characterization establishing gene structure, single study\",\n      \"pmids\": [\"7490077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A cis-regulatory enhancer located within an intron of Pde6c drives transient, cone-enriched expression in developing mouse and human retinal organoids; mutagenesis of the enhancer identified five or more essential transcription factor binding sites, implicating both known photoreceptor regulators and novel families in cone fate specification.\",\n      \"method\": \"Electroporation of enhancer-reporter constructs in mouse retina, transgenic human iPSC-derived retinal organoids, enhancer deletion/mutagenesis series\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional enhancer assay with mutagenesis in two systems (mouse and human organoids), single lab\",\n      \"pmids\": [\"35644251\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PDE6C encodes the catalytic alpha' subunit of the cone photoreceptor cGMP-phosphodiesterase (PDE6), which hydrolyzes cGMP to 5'-GMP in the phototransduction cascade; its activity is regulated by the inhibitory Pγ subunit, its stability in cones depends on AIPL1 and guanylate cyclase GC3, and disease-causing missense mutations produce distinct molecular defects—including loss of catalytic activity, altered Pγ sensitivity, proteolytic degradation via the GAFb domain, or mislocalization to non-outer-segment compartments—while loss of PDE6C function triggers RIP1/RIP3-mediated necroptotic cone death and secondary caspase-dependent rod bystander death.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PDE6C encodes the catalytic α′ subunit of cone photoreceptor cGMP phosphodiesterase (PDE6), which hydrolyzes cGMP to 5′-GMP as the essential effector enzyme of cone phototransduction [PMID:19615668, PMID:19887631]. Its catalytic activity is modulated by the inhibitory Pγ subunit, with disease-causing missense mutations producing distinct molecular defects: catalytic-domain mutations (e.g., H602L, E790K) abolish or reduce enzymatic activity and alter Pγ sensitivity, whereas GAF-domain mutations (R104W, Y323N, P391L) cause proteolytic degradation via cleavage in the GAFb domain, and mutations outside conserved domains (R29W, M455V) lead to aberrant subcellular compartmentalization [PMID:21127010, PMID:25461672]. PDE6C protein stability in cones depends on a mutual stabilization network with AIPL1 and guanylate cyclase GC3, and loss of PDE6C triggers RIP1/RIP3-mediated necroptotic cone death with secondary caspase-dependent rod bystander degeneration [PMID:28378769, PMID:24413151]. Biallelic loss-of-function mutations in PDE6C cause autosomal recessive achromatopsia [PMID:19615668, PMID:19887631].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing the genomic architecture of PDE6C resolved a foundational question about the structural relationship between cone and rod PDE catalytic subunits, revealing high conservation and a common evolutionary origin.\",\n      \"evidence\": \"Genomic cloning, exon-intron mapping, and chromosomal localization of the human PDE6C (PDEA2) gene\",\n      \"pmids\": [\"7490077\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional or biochemical data on the encoded protein were provided\", \"Regulatory elements controlling cone-specific expression were not identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of PDE6C as the disease gene for autosomal recessive achromatopsia established that the cone α′ PDE6 subunit is indispensable for cone function and survival, linking a specific phototransduction enzyme to a human Mendelian cone disorder.\",\n      \"evidence\": \"Homozygosity mapping and sequencing in human achromatopsia families; ERG, histology, and genetic analysis of the cpfl1 mouse carrying a homologous Pde6c mutation\",\n      \"pmids\": [\"19615668\", \"19887631\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical consequences of individual patient mutations were unknown\", \"Mechanism of cone cell death downstream of PDE6C loss was uncharacterized\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Biochemical characterization of six patient-derived missense mutations revealed that PDE6C disease alleles are not mechanistically uniform: some are catalytic nulls, while others differentially alter Pγ inhibitory sensitivity, indicating that both enzymatic activity and regulatory interactions are critical for cone PDE6 function.\",\n      \"evidence\": \"Baculovirus expression of chimeric PDE6C/PDE5 proteins in Sf9 cells with PDE activity assays, zaprinast inhibition, and quantitative Pγ IC50 determinations\",\n      \"pmids\": [\"21127010\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Assays used a chimeric PDE6C/PDE5 construct rather than full-length native PDE6C holoenzyme\", \"Whether altered Pγ sensitivity translates to distinct disease severity in vivo was not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Two studies resolved the downstream consequences of PDE6C loss at the cellular and protein-folding levels: GAF-domain mutations cause proteolytic degradation via the GAFb domain while catalytic-domain mutations permit outer-segment targeting, and loss of PDE6C activity triggers necroptotic (RIP1/RIP3-mediated) cone death with secondary caspase-dependent rod bystander apoptosis.\",\n      \"evidence\": \"Transgenic Xenopus laevis rod expression with subcellular fractionation, proteolytic stability assays, and immunofluorescence; zebrafish pde6c(w59) mutant with morpholino knockdown, RIP1/RIP3/caspase-3 immunostaining, pharmacological inhibition, and ROS assays\",\n      \"pmids\": [\"25461672\", \"24413151\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transgenic expression was in rods rather than native cone photoreceptors\", \"Whether necroptosis is the death pathway in mammalian cones lacking PDE6C is unknown\", \"Mechanism by which GAFb-domain cleavage is initiated remains unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstration that PDE6C stability depends on AIPL1 and guanylate cyclase GC3 revealed a mutual protein-stabilization network specific to cones, explaining why AIPL1 mutations phenocopy PDE6C loss.\",\n      \"evidence\": \"Zebrafish aipl1b (gosh) mutant genetic interaction analysis, morpholino knockdown of zGc3, immunostaining for Pde6c and zGc3 protein levels\",\n      \"pmids\": [\"28378769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physical interactions among AIPL1, PDE6C, and GC3 were not demonstrated biochemically\", \"Whether the stabilization network operates identically in mammalian cones is untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Discovery of a cis-regulatory enhancer within a Pde6c intron that drives cone-enriched expression identified specific transcription factor binding sites required for cone-specific gene regulation, extending understanding from protein function to transcriptional control.\",\n      \"evidence\": \"Enhancer-reporter electroporation in mouse retina and transgenic human iPSC-derived retinal organoids with systematic enhancer mutagenesis\",\n      \"pmids\": [\"35644251\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The upstream transcription factors binding these sites were not all identified\", \"Whether this enhancer is necessary for endogenous PDE6C expression (via enhancer knockout) was not shown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structure of the native cone PDE6C holoenzyme, the precise chaperone mechanism by which AIPL1 folds PDE6C, and whether therapeutic rescue of PDE6C in mammalian cones can prevent necroptotic degeneration remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of the cone PDE6C holoenzyme exists\", \"Chaperone mechanism of AIPL1 for PDE6C folding/assembly is uncharacterized\", \"Gene therapy rescue of PDE6C-null mammalian cones has not been demonstrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [\n      \"Cone PDE6 holoenzyme\"\n    ],\n    \"partners\": [\n      \"PDE6H\",\n      \"AIPL1\",\n      \"GUCY2F\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}